TY  - JOUR
AU  - Luque Carmona, Ana María
AU  - Ontanilla-Clavijo, Guillermo
AU  - Leo Carnerero, Eduardo
PY  - 2020
DO  - 10.17235/reed.2020.6886/2020
SN  - 1130-0108
UR  - http://hdl.handle.net/10668/16420
T2  - Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva
AB  - Immunotherapy is gaining significance in the management of oncological disease. It has demonstrated high levels of efficacy, though it also has hitherto unknown side effects, such as colitis. We present the first case of immune checkpoint inhibitor...
LA  - en
KW  - Colitis
KW  - Enterocolitis
KW  - Humans
KW  - Infliximab
KW  - Ipilimumab
KW  - Nivolumab
TI  - Severe enterocolitis secondary to ipilimumab and nivolumab with an excellent response to a single dose of infliximab.
TY  - research article
VL  - 112
ER  -